Image may be NSFW.
Clik here to view.
Shares in Anika Therapeutics (NSDQ:ANIK) fell in premarket activity today after the company missed expectations on Wall Street with its first-quarter results.
The Bedford, Mass.-based company swung to a net loss of -$6.7 million, or -46¢ per share, on sales of $21.3 million for the 3 months ended March 31, down -9.1% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Anika swings to a loss in Q1 appeared first on MassDevice.
